vimarsana.com

Page 47 - ப்ரொக்யூர்மெஂட் அமைச்சர் அனிதா ஆனந்த் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Canada paid extra for vaccines because it couldn t make its own: Anand

iPolitics By Charlie Pinkerton. Published on Apr 23, 2021 4:02pm AstraZeneca s COVID vaccine (WikiMedia Commons photo) Canada paid a higher price than other countries for AstraZeneca’s COVID vaccine because it didn’t have the manufacturing capacity to make doses itself, Procurement Minister Anita Anand said Friday. An email sent by a staffer in the Prime Minister’s Office on the eve of the announcement of Ottawa’s deal with AstraZeneca was made public last week, shining light for the first time on the exact price Ottawa paid for COVID vaccines. The price it negotiated with AstraZeneca $8.18 apiece for 20 million doses was more than twice what some ally countries have reportedly paid.

Very excited : Prime Minister Trudeau receives first dose of COVID-19 AstraZeneca vaccine

  OTTAWA Prime Minister Justin Trudeau and his wife, Sophie Gregoire Trudeau, received their first doses of the AstraZeneca COVID-19 vaccine on Friday. “I am very excited,” Trudeau said, going first to get his shot, which went into his left arm where he has a Haida raven tattoo. Seconds later, Trudeau offered an enthusiastic “yay” with two thumbs up before it was his wife’s turn. Ahead of their vaccines, which were administered at a local pharmacy not far from Parliament Hill, Trudeau said the pair was “looking forward” to it. “If you’re eligible for your vaccine like we are, make sure you get your dose as soon as possible,” Trudeau said during a COVID-19 update briefing on Friday.

COVID-19: Ontario reports first AZ-related case of rare blood clotting; Tam sees signs of easing

Article content Ottawa sees 254 new cases, no new deaths Canada signs deal for millions of vaccine boosters through 2023 Canadians aged 30 and over can now receive the AstraZeneca vaccine, according to updated guidance from the National Advisory Committee on Immunization. We apologize, but this video has failed to load. Try refreshing your browser. COVID-19: Agency approves AstraZeneca use in patients 30 and over; Tam sees signs of easing Back to video NACI chair Dr. Caroline Quach-Thanh and vice-chair Dr. Shelly Deeks said Canadians may now get the AstraZeneca vaccine “if they do not want to wait for an mRNA vaccine.” The agency was initially set to update its guidance on Tuesday, but decided to postpone while Health Canada analyzed COVID-19 activity in hot spots, and examined high incidence rates of variants of concern.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.